KRBP News and Press, Kiromic BioPharma Inc. From 09/14/23

Kiromic BioPharma Inc. (KRBP) is expected to report for quarter end 2023-06-30

2023-09-13 16:50:37 ET More on Kiromic BioPharma Financial information for Kiromic BioPharma For further details see: Kiromic BioPharma to list on Pink Sheets after Nasdaq trading suspension

KRBP Suspended from Trading on Nasdaq Kiromic BioPharma (NASDAQ: KRBP) (“Kiromic” or the “Company”) , a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence and data mining platform to d...

Clinical and Regulatory Affairs Expert Pamela Misajon Brings Drug-Development Expertise Finance and Technology Executive Michael Catlin to Chair the Audit Committee Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-st...

2023-06-30 12:31:22 ET Gainers: Cyteir Therapeutics ( CYT ) +39% . Renalytix ( RNLX ) +39% . Rackspace Technology ( RXT ) +29% . Friedman Industries ( FRD ) +23% . Gracell Biotechnologies ( GRCL ) +23% . CytomX Therapeutics (...

2023-06-30 10:06:37 ET Gainers: CymaBay Therapeutics ( CBAY ) +36% . Cyteir Therapeutics ( CYT ) +34% . Renalytix ( RNLX ) +32% . CytomX Therapeutics ( CTMX ) +14% . Alvotech ( ALVO ) +13% . Losers: Unicycive Therapeutics ...

2023-05-03 13:05:45 ET Gainers: ImmunoGen ( IMGN ) +124% . GD Culture Group Limited ( GDC ) +115% . Aptorum Group Limited ( APM ) +92% . Aceragen ( ACGN ) +77% . NantHealth ( NH ) +57% . Sentage Holdings ( SNTG ) +61% ...

2023-05-03 08:34:28 ET Aptorum Group  ( APM ) +153% . Akanda  ( AKAN ) +113% . ImmunoGen ( IMGN ) +96% surges ~95% as ovarian cancer drug Elahere shows survival benefit in confirmatory trial. Kiromic BioPharma, Inc. ( KRBP ) +59% ....

2023-05-01 10:03:58 ET Gainers: Nano-X Imaging ( NNOX ) +53% . Meihua International Medical Technologies ( MHUA ) +34% .  Minerva Neurosciences ( NERV ) +27% . Apollomics ( APLM ) +24% . Ascendis Pharma ( ASND ) +19% . ...

Company Expects Beginning of First in Human Trial Activation in Second Quarter of 2023 Deltacel is Being Developed to Treat Solid Malignancies, Which Comprise 90% of All Cancers Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), ...